ShockWave Medical Ownership | Who Owns ShockWave Medical?
ShockWave Medical Ownership Summary
ShockWave Medical is owned by 98.88% institutional investors, and 1.12% retail investors. Algert global is the largest institutional shareholder, holding 0% of SWAV shares. Vanguard Health Care Inv is the top mutual fund, with 2.11% of its assets in ShockWave Medical shares.
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Algert global | - | - | - |
Park place capital | - | - | - |
Slatestone wealth | - | - | - |
Princeton capital management | - | - | - |
Holocene advisors, lp | - | - | - |
First trust advisors lp | - | - | - |
Woodline partners lp | - | - | - |
Financial gravity asset management | - | - | - |
Davidson kempner capital management lp | - | - | - |
Bnp paribas asset management | - | - | - |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Algert global | - | - | - |
Park place capital | - | - | - |
Slatestone wealth | - | - | - |
Princeton capital management | - | - | - |
Holocene advisors, lp | - | - | - |
First trust advisors lp | - | - | - |
Woodline partners lp | - | - | - |
Financial gravity asset management | - | - | - |
Davidson kempner capital management lp | - | - | - |
Bnp paribas asset management | - | - | - |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Parkside financial bank & trust | - | - | -1.00 |
Smartleaf asset management | - | - | -1.00 |
Manchester capital management | - | - | -1.00 |
Cornerstone planning group | - | - | -1.00 |
Sjs investment consulting | - | - | -2.00 |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Blackrock | - | - | -3.78M |
Vanguard group | - | - | -3.64M |
Wellington management group llp | - | - | -2.61M |
Fmr | - | - | -2.59M |
Artisan partners limited partnership | - | - | -1.53M |
Sold Out
Holder | Change |
---|---|
Parkside financial bank & trust | -1.00 |
Smartleaf asset management | -1.00 |
Manchester capital management | -1.00 |
Cornerstone planning group | -1.00 |
Sjs investment consulting | -2.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Mar 31, 2024 | 518 | 14.86% | 36,295,778 | 2.03% | 98 | 1.06% | 273 | 18.18% | 157 | 3.29% |
Dec 31, 2023 | 451 | 4.88% | 35,572,123 | 5.24% | 96 | 1.14% | 231 | 11.06% | 152 | -1.30% |
Sep 30, 2023 | 430 | -10.42% | 33,801,398 | 3.44% | 92 | 1.15% | 208 | -11.86% | 154 | -11.49% |
Jun 30, 2023 | 480 | 22.45% | 32,676,025 | -3.73% | 89 | 1.03% | 236 | 12.92% | 174 | 40.32% |
Mar 31, 2023 | 392 | -7.55% | 33,940,855 | 4.79% | 93 | 1.16% | 209 | -5.86% | 124 | -17.33% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Vanguard Health Care Inv | 793.51K | 2.11% | 112.13K |
JPM US Mid Cap Growth-Composite | 354.71K | 0.94% | 354.71K |
Eventide Gilead N | 296.54K | 0.79% | - |
Lord Abbett & Co. Growth Equity- SA | 224.21K | 0.60% | 224.21K |
PRIMECAP Odyssey Aggressive Growth | 215.30K | 0.57% | -5.30K |
Fidelity Extended Market Index | 209.01K | 0.56% | 225.00 |
Vanguard Explorer Inv | 205.26K | 0.55% | 45.30K |
Eventide Healthcare & Life Sciences I | 198.86K | 0.53% | - |
Janus Henderson US SMID Cap Growth | 189.48K | 0.50% | -2.55K |
AB Discovery Growth A | 158.11K | 0.42% | -1.11K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Mar 26, 2024 | FRANCIS LAURA | - | Sell | $450.00K |
Mar 26, 2024 | Zacharias Isaac | President, CCO | Sell | $1.15M |
Mar 06, 2024 | WATKINS FRANK T | - | Sell | $329.10K |
Mar 06, 2024 | WATKINS FRANK T | - | Sell | $178.20K |
Mar 06, 2024 | Phung Trinh | VP, Finance | Sell | $5.32K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2024 Q2 | - | - |
2024 Q1 | - | 46 |
2023 Q4 | - | 29 |
2023 Q3 | - | 31 |
2023 Q2 | - | 18 |
SWAV Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools